ArticleClinical & experimental metastasis2008

Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy.

Stuart Thomson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.